We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis and Par Pharmaceutical Taken to Court Over Pay-For-Delay
Novartis and Par Pharmaceutical Taken to Court Over Pay-For-Delay
Novartis and Par Pharmaceutical were hit with a pay-for-delay lawsuit filed by Puerto Rican drug manufacturer Drogueria Betances alleging the two companies engaged in years of anticompetitive conduct that delayed generic competition for the hypertension drug, Exforge.